Target intelligence / Profile preview

Penicillin-binding protein 3 and Penicillin-binding protein 1b (PBP3 and PBP1b)

Target
PBP3 and PBP1b
Molecular classification
Enzyme, Transpeptidase, Glycosyltransferase, Penicillin-binding protein, Acyl-serine transferase
01

Overview

Penicillin-binding proteins (PBPs) are essential enzymes located in the bacterial periplasm of Gram-negative bacteria, where they catalyze the final stages of peptidoglycan cell wall assembly (Sauvage et al., 2008). Penicillin-binding protein 3 (PBP3, also known as FtsI) is a class B PBP that functions as a monofunctional transpeptidase specifically required for septum formation during cell division (UniProt P0AD68; Wikipedia). Penicillin-binding protein 1b (PBP1b, also known as PonA or MrcB) is a class A PBP that possesses bifunctional glycosyltransferase and transpeptidase activities, contributing to both cell wall synthesis and repair (UniProt P02919; NIH). These proteins are the primary targets of beta-lactam antibiotics, which covalently bind to the active site serine, inhibiting the cross-linking of peptidoglycan strands. This inhibition compromises the structural integrity of the bacterial cell wall, leading to cell filamentation (in the case of PBP3 inhibition), lysis, and death (StatPearls). Resistance to drugs targeting these PBPs is a major clinical challenge, often mediated by the production of beta-lactamases or mutations in the PBP genes that reduce drug affinity (PubMed).

Other names
FtsIPonAMrcBSeptum formation protein IBifunctional transglycosylase-transpeptidase PBP1bPBP-3PBP-1b
02

Mechanism of action

Covalent inhibition of the transpeptidase domain via acylation of the catalytic serine residue, which mimics the D-alanyl-D-alanine substrate and prevents the cross-linking of peptidoglycan chains, leading to cell wall lysis (Sauvage et al., 2008; NIH).

03

Biological functions

Peptidoglycan biosynthesisCell wall synthesisCell divisionCell wall repairSeptation
04

Disease associations

Infection
05

Safety considerations

Antibiotic resistance (e.g., NDM-1, KPC)Hypersensitivity reactions (Penicillin allergy)Disruption of commensal microbiotaRisk of Clostridioides difficile infection
06

Interacting drugs

Aztreonam

10 more in the full profile.

07

Biomarkers

Minimum Inhibitory Concentration (MIC)PBP occupancy (Bocillin-FL)Bacterial filamentation

Beyond the preview

Go deeper on Penicillin-binding protein 3 and Penicillin-binding protein 1b (PBP3 and PBP1b).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Penicillin-binding protein 3 and Penicillin-binding protein 1b (PBP3 and PBP1b).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call